RIDGELINE THERAPEUTICS LLC
Home | Ridgeline
HOUSTON, United States · Founded 2018
- Headquarters
- HOUSTON, Texas
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2B
- Website
- ridgelinetherapeutics.com
- Last Round
- GrantSep 2018
- Rounds
- 2
About
Ridgeline Therapeutics is a Houston-based biotech company developing first-in-class small molecule inhibitors targeting nicotinamide N-methyltransferase (NNMT) to reverse age-related muscle weakness, Type 2 diabetes, obesity, muscular dystrophies, and kidney disease. The company's technology was invented at the University of Texas Medical Branch and is backed by NIH SBIR funding.
Summary
RIDGELINE THERAPEUTICS LLC is a Biotech company based in HOUSTON, United States, founded in 2018. Its most recent funding was a Grant round in Sep 2018. Investors include Department of Health and Human Services.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2018
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.